A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies
Conditions
Advanced Solid Cancers
What is the purpose of this trial?
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- AstraZeneca
- Dates:
- September 2011
- Last Updated:
- Study HIC#:
- 1107008821
Clinicaltrials.gov ID: Yale7349468
For more information about this trial, contact:
Noelle Sowers
203-737-3472
noelle.sowers@yale.edu
Investigator
Howard Hochster, MD
Principal Investigator
